Norfloxacin therapy for hepatopulmonary syndrome: A pilot randomized controlled trial

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 12, 2010, Pages 1095-1098

  Gupta, Samir ^a,b,c   Faughnan, Marie E ^a,b,c   Lilly, Les ^d   Hutchison, Stuart ^e   Fowler, Robert ^a,f   Bayoumi, Ahmed M ^a,b,c,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bacterial Translocation; Endotoxins; Nitric Oxide; Pulmonary Circulation

Indexed keywords

NORFLOXACIN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEASIBILITY STUDY; FEMALE; HEPATOPULMONARY SYNDROME; HUMAN; LUNG ALVEOLUS OXYGEN TENSION; MALE; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CROSS-OVER STUDIES; FEMALE; HEPATOPULMONARY SYNDROME; HUMANS; MALE; MIDDLE AGED; NORFLOXACIN; PILOT PROJECTS; PULMONARY GAS EXCHANGE; TREATMENT OUTCOME;

EID: 78649710252     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.08.011     Document Type: Article

References (20)

1. Rodriguez-Roisin R., Krowka M.J. Hepatopulmonary syndrome: a liver-induced lung vascular disorder. N Engl J Med 2008, 358:2378-2387.
2. Fallon M.B., Krowka M.J., Brown R.S., et al. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology 2008, 135:1168-1175.
3. Rabiller A., Nunes H., Lebrec D., et al. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 2002, 166:514-517.
4. Zhang J., Ling Y., Tang L., et al. Pentoxifylline attenuation of experimental hepatopulmonary syndrome. J Appl Physiol 2007, 102:949-955.
5. Nunes H., Lebrec D., Mazmanian M., et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 2001, 164:879-885.
6. Sogni P., Garnier P., Gadano A., et al. Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis. J Hepatol 1995, 23:471-473.
7. Rolla G., Brussino L., Colagrande P., et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology 1997, 26:842-847.
8. Albillos A., Hera A., Ade L., et al. Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin. J Hepatol 2004, 40:624-631.
9. Anel R.M., Sheagren J.N. Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents. Clin Infect Dis 2001, 32:E131-E136.
10. Lee W.L., Graham A.F., Pugash R.A., et al. Contrast echocardiography remains positive after treatment of pulmonary arteriovenous malformations. Chest 2003, 123:351-358.
11. Delclaux C., Mahut B., Zerah-Lancner F., et al. Increased nitric oxide output from alveolar origin during liver cirrhosis versus bronchial source during asthma. Am J Respir Crit Care Med 2002, 165:332-337.
12. Macintyre N., Crapo R.O., Viegi G., et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005, 26:720-735.
13. Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117. American Thoracic Society (ATS).
14. Tanikella R., Philips G.M., Faulk D.K., et al. Pilot study of pentoxifylline in hepatopulmonary syndrome. Liver Transplant 2008, 14:1199-1203.
15. Taille C., Cadranel J., Bellocq A., et al. Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation 2003, 75:1482-1489. discussion:46-47.
16. Gupta S., Castel H., Rao R., et al. Improved survival after liver transplantation in patients with hepatopulmonary syndrome. Am J Transplant 2010, 10:354-363.
17. Arguedas M.R., Abrams G.A., Krowka M.J., et al. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003, 37:192-197.
18. Fallon M.B. Hepatopulmonary syndrome: more than just a matter of tone?. Hepatology 2006, 43:912-914.
19. Liu Q., Duan Z.P., Ha D.K., et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004, 39:1441-1449.
20. Gentile S., Guarino G., Romano M., et al. A randomized controlled trial of acarbose in hepatic encephalopathy. Clin Gastroenterol Hepatol 2005, 3:184-191.